About
Glibenclamide and Metformin is a widely prescribed combination medication utilized in the comprehensive management of type 2 diabetes mellitus, particularly when lifestyle interventions such as diet and exercise alone, or monotherapy with either agent, fail to achieve adequate glycemic control. Glibenclamide, a potent sulfonylurea, acts by stimulating the pancreatic beta cells to increase insulin secretion, thereby directly lowering blood glucose levels. Concurrently, Metformin, a biguanide, exerts its effects by primarily reducing the liver's glucose production, decreasing the absorption of glucose from the intestines, and enhancing insulin sensitivity in peripheral tissues, leading to improved glucose uptake and utilization.
The synergistic action of these two distinct pharmacological agents allows for a more robust and multifaceted approach to glycemic control, effectively addressing both the impaired insulin secretion and the underlying insulin resistance characteristic of type 2 diabetes. This combination represents a cornerstone therapy for many patients requiring intensified glucose-lowering strategies.
Uses
- Treatment of type 2 diabetes mellitus.
- Improvement of glycemic control.
- When diet and exercise are inadequate.
- As an alternative to separate glibenclamide and metformin tablets.
Directions For Use
Take this medication orally, usually with meals, as directed by your physician. Follow the prescribed dosage and schedule carefully.
Benefits
- Potent blood glucose lowering effect.
- Addresses both insulin secretion and insulin resistance.
- Significantly reduces HbA1c levels.
- Well-established and widely used combination.
- Cost-effective treatment option.
- Improves overall metabolic control.
Side Effects
- Hypoglycemia (common due to glibenclamide)
- Nausea
- Diarrhea
- Abdominal pain
- Weight gain (due to glibenclamide)
- Headache
- Dizziness
- Metallic taste (due to metformin)
- Skin rash
- Lactic acidosis (rare, due to metformin)
- Vitamin B12 deficiency (long-term metformin use)
- Liver enzyme elevation (rare)
Safety Measures
- Alcohol - Avoid alcohol due to increased risk of hypoglycemia (glibenclamide) and lactic acidosis (metformin).
- Pregnancy - Not recommended during pregnancy. Insulin is generally preferred for glycemic control in pregnant women with diabetes.
- Breastfeeding - Metformin is excreted in breast milk; glibenclamide's excretion is unknown. Use with caution; consult a healthcare professional.
- Liver - Contraindicated in severe liver impairment due to increased risk of lactic acidosis and hypoglycemia.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to metformin. Dosage adjustment needed for moderate impairment.
- Lung - Generally safe for use in patients with lung conditions; however, severe respiratory failure can increase lactic acidosis risk with metformin.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!